Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Micronization as a Bioavailability Enhancement Tool

October 06, 2014

Pharmaceutical Technology Europe spoke with Piero Iamartino, R&D director at Micro-Macinazione, about the role of micronization in pharmaceutical manufacturing.

CMO Consolidation Continues

October 06, 2014

The last 12 months have seen a number of major acquisitions in the contract manufacturing space.

Milan API Producer Opens High-Potent API Plant

October 03, 2014

LABOCHIM SpA completes construction on multipurpose high-potent API plant in Milan.

Biopharma Manufacturers Respond to Ebola Crisis

October 02, 2014

Demand for new therapies and vaccines spotlights production challenges.

Romaco Kilian's Tablet Press Introduces Continuous Weight Control

October 02, 2014

Romaco Kilian's KTP 420X tablet press compresses up to 360,000 tablets an hour.

Fette Tablet Press Designed for High Production

October 02, 2014

Fette Compacting America FE75 Tablet Press is designed to produce up to 1.6 million tablets per hour.

Solving Poor Solubility with Amorphous Solid Dispersions

October 02, 2014

Weighing the pros and cons of hot-melt extrusion and spray drying.

Harmonizing Marketing Approval of Generic Drugs in Europe

October 02, 2014

Regulatory agencies in Europe are working to harmonize the marketing approval pathway of generic medicines.

New Technologies Enhance the Formulation of Highly Potent Drugs

October 02, 2014

Advances in solid and liquid formulation techniques are providing more options.

NIH Seeks to Improve Vaccine Response with New Adjuvants

September 30, 2014

NIH seeks new therapeutic products to bolster the protective properties of vaccines.